Wyching Ng

Dr. Wyching Ng


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 June 2017 in Viruses
Verified
Journal Article
Open access
PDF file
WNWyching Ng
Wyching Ng
RSRuben Soto-Acosta
Ruben Soto-Acosta
SBShelton Bradrick
Shelton Bradrick
MGMariano Garcia-Blanco
Mariano Garcia-Blanco
EOEng Eong Ooi
Eng Eong Ooi
Flaviviruses are enveloped arthropod-borne viruses with a single-stranded, positive-sense RNA genome that can cause serious illness in humans and animals. The 11 kb 5′ capped RNA genome consists of a single open reading frame (ORF), and is flanked by 5′ and 3′ untranslated regions (UTR). The ORF is a polyprotein that is processed into three structural and seven non-structural proteins. The UTRs have been shown to be important for viral replication and immune modulation. Both of these regions consist of elements that are essential for genome cyclization, resulting in initiation of RNA synthesis. Genome mutation studies have been employed to investigate each component of the essential elements to show the necessity of each component and its role in viral RNA replication and growth. Furthermore, the highly structured 3′UTR is responsible for the generation of subgenomic flavivirus RNA (sfRNA) that helps the virus evade host immune response, thereby affecting viral pathogenesis. In addition, changes within the 3′UTR have been shown to affect transmissibility between vector and host, which can influence the development of vaccines.

14 December 2022 in Open Biology
Verified
Journal Article
Open access
WNWyching Ng
Wyching Ng
SKSwee Sen Kwek
Swee Sen Kwek
BSBo Sun
Bo Sun
MYMeisam Yousefi
Meisam Yousefi
EOEugenia Z. Ong
Eugenia Z. Ong
EOEng Eong Ooi
Eng Eong Ooi
The four dengue viruses (DENVs) have evolved multiple mechanisms to ensure its survival. Among these mechanisms is the ability to regulate its replication rate, which may contribute to avoiding premature immune activation that limit infection dissemination: DENVs associated with dengue epidemics have shown slower replication rate than pre-epidemic strains. Correspondingly, wild-type DENVs replicate more slowly than their clinically attenuated derivatives. To understand how DENVs ‘make haste slowly’, we generated and screened for DENV2 mutants with accelerated replication that also induced high type-I interferon (IFN) expression in infected cells. We chanced upon a single NS2B-I114T amino acid substitution, in an otherwise highly conserved amino acid residue. Accelerated DENV2 replication damaged host DNA as mutant infection was dependent on host DNA damage repair factors, namely RAD21, EID3 and NEK5. DNA damage induced cGAS/STING signalling and activated early type-I IFN response that inhibited infection dissemination. Unexpectedly, STING activation also supported mutant DENV replication in infected cells through STING-induced autophagy. Our findings thus show that DENV NS2B has multi-faceted role in controlling DENV replication rate and immune evasion and suggest that the dual role of STING in supporting virus replication within infected cells but inhibiting infection dissemination could be particularly advantageous for live attenuated vaccine development.

14 May 2024 in EMBO Molecular Medicine
Verified
Journal Article
Open access
DMDarren Zhi Liang Mok
Darren Zhi Liang Mok
DTDanny Jh Tng
Danny Jh Tng
JYJia Xin Yee
Jia Xin Yee
VCValerie Sy Chew
Valerie Sy Chew
CTChristine Yl Tham
Christine Yl Tham
JLJenny G Low
Jenny G Low
Vaccination has successfully controlled several infectious diseases although better vaccines remain desirable. Host response to vaccination studies have identified correlates of vaccine immunogenicity that could be useful to guide development and selection of future vaccines. However, it remains unclear whether these findings represent mere statistical correlations or reflect functional associations with vaccine immunogenicity. Functional associations, rather than statistical correlates, would offer mechanistic insights into vaccine-induced adaptive immunity. Through a human experimental study to test the immunomodulatory properties of metformin, an anti-diabetic drug, we chanced upon a functional determinant of neutralizing antibodies. Although vaccine viremia is a known correlate of antibody response, we found that in healthy volunteers with no detectable or low yellow fever 17D viremia, metformin-treated volunteers elicited higher neutralizing antibody titers than placebo-treated volunteers. Transcriptional and metabolomic analyses collectively showed that a brief course of metformin, started 3 days prior to YF17D vaccination and stopped at 3 days after vaccination, expanded oxidative phosphorylation and protein translation capacities. These increased capacities directly correlated with YF17D neutralizing antibody titers, with reduced reactive oxygen species response compared to placebo-treated volunteers. Our findings thus demonstrate a functional association between cellular respiration and vaccine-induced humoral immunity and suggest potential approaches to enhancing vaccine immunogenicity.

2 July 2024 in Microbiology Spectrum
Verified
Journal Article
Open access
WNWyching Ng
Wyching Ng
LLLowell Lin
Lowell Lin
TSTanamas Siriphanitchakorn
Tanamas Siriphanitchakorn
MJMargaret Ke Xin Jiang
Margaret Ke Xin Jiang
HTHwee Cheng Tan
Hwee Cheng Tan
EOEng Eong Ooi
Eng Eong Ooi

7 May 2025 in Research Square
Verified
Preprint
Open access
PDF file
EOEng Eong Ooi
Eng Eong Ooi
KKKiven Kumar
Kiven Kumar
JOJustin Ooi
Justin Ooi
HTHwee Cheng Tan
Hwee Cheng Tan
XLXudong Lyu
Xudong Lyu
EBEsteban Finol Berrueta
Esteban Finol Berrueta
Viral antigenic burden drives the inflammation-driven pathophysiology of dengue in humans. Nonetheless, the control of dengue virus (DENV) antigen expression for pathogenicity in humans remain uncertain. Herein, we examined a clinical DENV-3 isolate (Sleman/78), along with its partially and fully attenuated derivatives through 30- (Δ30) as well as 30- and 31-nucleotide deletions (Δ30/31), respectively, in the 3’ untranslated region (3′UTR) of the RNA genome; the partially and fully attenuated phenotypes of these derivatives were demonstrated in clinical trials. We found, using infectious clone technology, protein and RNA pulldown approaches, that the wild-type 3’UTR bound host translation proteins, including non-canonical eukaryotic initiation factor-3D (EIF3D) to support viral protein expression. Both Δ30/31 mutation and EIF3D silencing attenuated viral protein expression and hence replication of Sleman/78. As DENV genome is cyclized through 5’ and 3’UTR interactions, our findings the role of 3′UTR in regulating translation for infection and pathogenesis in humans.

10 September 2026 in npj Vaccines
Verified
Journal Article
Open access
PDF file
KKKiven Kumar
Kiven Kumar
JOJustin Sg Ooi
Justin Sg Ooi
CLCharlene H. M. Leong
Charlene H. M. Leong
HTHwee Cheng Tan
Hwee Cheng Tan
WNWyching Ng
Wyching Ng
EOEng Eong Ooi
Eng Eong Ooi
The live attenuated tetravalent dengue vaccine candidate, TV003 has now completed phase III clinical trial and is now licensed in Brazil. It is composed of DENV-1 and -4 that were attenuated through 30-nucleotide deletion (Δ30) in the 3’ untranslated region (3’UTR); the DENV-4 Δ30 backbone was also used to construct a chimeric virus bearing the pre-membrane and envelope genes of DENV-2. Attenuation of DENV-3 required an additional 31-nucleotide deletion (Δ30/31) in the 3’UTR. The reason for why two stretches of 3’UTR nucleotide deletions were needed to attenuate DENV-3, however, has remained undefined. Herein, we examined the DENV-3 (Δ30/31) against its wild-type Sleman/78 parent, as well as a partially attenuated DENV-3 (Δ30). We found using protein and RNA pulldown approaches, that wild-type 3’UTR bound host translation proteins, including ribosomal proteins and non-canonical eukaryotic initiation factor-3D (EIF3D) and EIF3K to support viral protein expression. Reduced binding of EIF3D and EIF3K to the Δ30/31 but not Δ30 mutant significantly reduced viral genome translation and replication. Correspondingly, silencing several of these proteins, including EIF3D, reduced viral protein expression and consequently decreased Sleman/78 and the Δ30 mutant replication. Notably, silencing EIF4E showed no statistically significant difference in viral replication, suggesting a functional role of EIF3 complex in DENV-3 genome translation. We also show that whilst Δ30 attenuated DENV-1 and -4, this deletion alone did not compromise DENV-2 translation, which could, at least partly, explain the reactogenicity profiles of these mutants in clinical trials. Our findings clarify the interacting partners of DENV 3’UTR and even suggest a path forward for updating the vaccine components, if necessary, with more contemporaneous DENVs.